Ποια είναι η τιμή για Genomics BioSci & Tech. Co.,Ltd. (4195)

Η τιμή για Genomics BioSci & Tech. Co.,Ltd. (4195) είναι $0.54058348

Ποια είναι η κεφαλαιοποίηση αγοράς για Genomics BioSci & Tech. Co.,Ltd. (4195)

Η κεφαλαιοποίηση αγοράς για Genomics BioSci & Tech. Co.,Ltd. (4195) είναι $39.16M

Genomics BioSci & Tech. Co.,Ltd. (4195) Τιμή και Κεφαλαιοποίηση Αγοράς

Genomics BioSci & Tech. Co.,Ltd. specializes in providing a comprehensive array of services within the field of genomic sequencing. Its core offerings encompass standard and intricate DNA sequencing, including TAF-certified options, with clients also benefiting from complimentary sequencing primer and primer walking services. Beyond sequencing, the company is proficient in synthesizing peptides, genes, and oligonucleotides. Furthermore, its analytical capabilities extend to crucial laboratory services such as sample preparation, gene expression analysis, genotyping, DNA methylation analysis, and microbial identification. The firm also delivers advanced sequencing solutions, including genome-level, targeted, gene regulation, and metagenomic sequencing, alongside cutting-edge third-generation sequencing technologies. To support these services, it offers integrated sequencing platforms and streamlined workflows. Additionally, Genomics BioSci & Tech. Co.,Ltd. provides specialized diagnostic screenings, such as non-invasive prenatal testing (NIPT), spinal muscular atrophy (SMA) carrier screening, and fragile X syndrome premutation screening. Established in 2001, the company's headquarters are located in New Taipei City, Taiwan.

Η τιμή για 4195	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$73,252.74 $39.16M	NVDA	$5.307T	+13,550,581.49%
$64,838.51 $39.16M	AAPL	$4.697T	+11,994,072.15%
$57,238.82 $39.16M	GOOG	$4.147T	+10,588,240.25%
$49,465.06 $39.16M	MSFT	$3.584T	+9,150,209.34%
$39,123.81 $39.16M	AMZN	$2.834T	+7,237,230.70%

Η τιμή για 4195

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$73,252.74 $39.16M